COMBINATION OF NATEGLINIDE OR REPAGLINIDE WITH AT LEAST ONE FURTHER ANTIDIABETIC COMPOUND

摘要

The present invention relates to a combination of organic compounds which comprises at least two antidiabetic agents, preferably with different modes of action, in which the active ingredients are in each case present in free form or in the form of a pharmaceutically acceptable salt and, optionally, at least on pharmaceutically acceptable carrier, for simultaneous, separate or sequential use.